https://invesbrain.com/regen-biopharma-inc-otcmkts-rgbp-breaking-out-as-biotech-files-patent-on-dendritic-cell-technologies-to-augment-efficacy-of-survivin-mrna-cancer-immunotherapeutic-vaccine/